Amphora Discovery Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

Amphora Discovery General Information

Description

Provider of pathway-based drug discovery services. The company's lead generation platform delivers unmatched precision, selectivity and data quality, which has produced well characterized proprietary new clinical entities for use in oncology, inflammation, metabolic diseases and neurological disorders. Amphora's most advanced compounds are preclinical candidates in the areas of oncology and inflammation which are exquisitely specific inhibitors for AKT1 and p38 respectively.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 800 Capitola Drive
  • Suite 4
  • Durham, NC 27713
  • United States
+1 (919)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Acquirer
Vertical(s)
Corporate Office
  • 800 Capitola Drive
  • Suite 4
  • Durham, NC 27713
  • United States
+1 (919)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Amphora Discovery Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 21-Oct-2008 Completed Generating Revenue
5. Later Stage VC (Series E) 01-Feb-2006 Completed Generating Revenue
4. Later Stage VC (Series D) 30-May-2005 Completed Generating Revenue
3. Later Stage VC (Series C) 08-Dec-2004 Completed Generating Revenue
2. Early Stage VC (Series B) 01-Dec-2002 $23M $48M Completed Generating Revenue
1. Early Stage VC (Series A) 01-Jan-2001 $25M $25M Completed Product Development
To view Amphora Discovery’s complete valuation and funding history, request access »

Amphora Discovery Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series E1
Series E
Series D
Series C
Series B
Series A1 23,750,000 $0.001000 $0.08 $1 $1 1x $0.71 20.22%
Series A 1,300,000 $0.001000 $0.08 $100000
To view Amphora Discovery’s complete cap table history, request access »

Amphora Discovery Former Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
3i Group PE/Buyout Minority
ARCH Venture Partners Venture Capital Minority
Aventis Corporation Minority
CW Group Venture Capital Minority
Chevron Technology Ventures Corporate Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Amphora Discovery FAQs

  • When was Amphora Discovery founded?

    Amphora Discovery was founded in 2001.

  • Where is Amphora Discovery headquartered?

    Amphora Discovery is headquartered in Durham, NC.

  • What industry is Amphora Discovery in?

    Amphora Discovery’s primary industry is Drug Discovery.

  • Is Amphora Discovery a private or public company?

    Amphora Discovery is a Private company.

  • What is Amphora Discovery’s current revenue?

    The current revenue for Amphora Discovery is .

  • How much funding has Amphora Discovery raised over time?

    Amphora Discovery has raised $81.9M.

  • Who are Amphora Discovery’s investors?

    3i Group, ARCH Venture Partners, Aventis, CW Group, and Chevron Technology Ventures are 5 of 9 investors who have invested in Amphora Discovery.

  • When was Amphora Discovery acquired?

    Amphora Discovery was acquired on 21-Oct-2008.

  • Who acquired Amphora Discovery?

    Amphora Discovery was acquired by Nanosyn.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process